Showing results (161-170 of 198) with videos related to
Sort By:
Pageof 20
Leukemia Research|January 1, 1985
Cryopreserved autologous bone marrow infusion following high dose chemotherapy in patients with acute myeloblastic leukemia in first relapseG Meloni, P De Fabritiis, G Papa, et al.Haematologica|January 1, 1989
Results of two different conditioning regimens followed by ABMT in refractory acute lymphoblastic leukemiaG Meloni, P De Fabritiis, A Pulsoni, et al.Journal of Leukocyte Biology|October 10, 2024
The miniaturized isolation of neutrophil granules (MING) method allowed a deep proteome mapping of human neutrophil granulesGabrielly Alexandria, Hellen P Valerio, Mariana P Massafera, et al.JAMA|January 8, 1982
Percutaneous radiographically guided catheter drainage of abdominal abscessesE vanSonnenberg, J T Ferrucci, P R Mueller, et al.Journal of Biological Regulators and Homeostatic Agents|July 1, 1992
In vitro antitumor effect of LAK cells and alpha interferon in combination on tumor cell linesA Sandrelli, P De Fabritiis, G D Di Nucci, et al.Proceedings of the National Academy of Sciences of the United States of America|September 3, 2021
AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylaseYohei Yoshihama, Kyle A LaBella, Eiru Kim, et al.Immunopharmacology and Immunotoxicology|April 5, 2005
Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophagesL Passantino, R Patruno, P Valerio, et al.Blood|June 22, 2001
EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion proteinF Simone, P E Polak, J J Kaberlein, et al.Molecular and Cellular Biology|July 21, 2001
The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesisR T Luo, C Lavau, C Du, et al.Pageof 20